The Food and Drug Administration () has revoked authorization of ’s Covid vaccine after it was paused over rare blood clot concerns, which sent demand plummeting. The move was not unexpected because J&J’s parent company Jannsen had requested that federal regulators at the FDA withdraw authorization for its vaccine after it was revealed that the last tranche of doses – about 12.5 million – had expired.As of year three of the Covid pandemic, nearly 231 million Americans have received either one J&J shot or two doses of an mRNA vaccine from Pfizer or .
Load More
Load More